Overview
Semaglutide is studied as a GLP-1 receptor agonist research peptide in laboratory models of incretin signaling, metabolic pathways, and glucose-dependent cellular response. It is supplied as lyophilized powder across multiple available presentations for laboratory research workflows only.





